You searched for "clinic"
Licence to save: a UK survey of anti-VEGF use for the eye
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...Myasthenia gravis presenting with isolated ptosis: a poorly studied subgroup
Investigation into the cause of one isolated symptom or sign can be challenging if that particular sign may be caused by a variety of pathological processes, affecting different tissues, and presenting to different specialties. Unilateral ptosis is a case in...Q&A: Mr Goel and Mr Loomba on alcohol delamination and phototherapeutic keratectomy (PTK) for the treatment of recurrent corneal erosion syndrome
Recurrent corneal erosion syndrome is a common, recurrent condition caused by abnormal epithelial adhesion to the underlying basal lamina. Spontaneous breakdown of the corneal epithelium can lead to the sudden onset of ocular pain, blurred vision, tearing and photophobia, typically...How good does my vision have to be to drive this thing? Visual standards for various occupations
We can all picture that moment in clinic: you are about to tell someone that they’re no longer legally able to drive, ready to deploy our ‘breaking bad news’ techniques. For some patients this may have been expected, or they...In conversation with Yasmin El-Rouby
Author and Eye Doctor, Dr Yasmin El-Rouby, wishes to raise awareness about common vision disorders. Envisioning a world where preventable eye conditions are caught early, she founded Baseera, a non-profit organisation, to improve access to basic eyecare in developing countries....Strengthening eye care services in Botswana through the Botswana-Addenbrooke’s Abroad VISION 2020 LINK
The VISION 2020 LINK between Botswana and Addenbrooke’s Abroad has been running for 10 years. With support from the VISION 2020 LINKS Programme two-way exchange visits were undertaken leading to the formation of the first formal international partnership under Addenbrooke’s...Tackling diabetic retinopathy globally through the VISION 2020 LINKS Diabetic Retinopathy Network
It is abundantly clear that the burden of diabetes is rapidly increasing, as there are now 415 million adults with diabetes in the world, with a projected rise to 642 million by 2040 [1]. This equates to 1 in 10...Glaucoma-NET: a novel way of improving glaucoma management in sub-Saharan Africa
Background Glaucoma is the second most common cause of blindness worldwide [1]. People with untreated glaucoma suffer from irreversible, progressive loss of sight. The disease is characterised by progressive loss of visual field, with pathological cupping of the optic disc...New runners inspired by London Marathon warned to consider their eye health amid thousands of sign-ups ahead of the event
Runners and would-be runners have been urged to ensure they have considered the best options for their eyesight if they are inspired to be more active by this year’s London Marathon.Scope Eyecare announces winners of Independent Prescriber Bursary Awards 2023
The final of the 2023 SCOPE IP Bursary Awards took place on Thursday 29 June 2023. The award, now in its second year, attracted many entries the quality of which were extremely high.
